Labiana Health, S.A. (BME:LAB)

Spain flag Spain · Delayed Price · Currency is EUR
7.50
+0.20 (2.74%)
At close: Apr 28, 2026
146.71%
Market Cap 60.32M
Revenue (ttm) 71.67M
Net Income (ttm) 904.36K
Shares Out 8.26M
EPS (ttm) 0.13
PE Ratio 56.47
Forward PE 16.30
Dividend n/a
Ex-Dividend Date n/a
Volume 49,942
Average Volume 25,975
Open 7.50
Previous Close 7.30
Day's Range 7.10 - 7.50
52-Week Range 3.06 - 7.90
Beta 0.17
RSI 81.63
Earnings Date Apr 21, 2026

About Labiana Health

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, bacterial vaccines and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contrac... [Read more]

Sector Healthcare
Founded 1958
Employees 394
Stock Exchange Madrid Stock Exchange
Ticker Symbol LAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.